Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Revenue

Optipharm.CO.,LTD had revenue of 5.36B KRW in the quarter ending March 31, 2026, with 9.01% growth. This brings the company's revenue in the last twelve months to 22.79B, up 12.51% year-over-year. In the year 2025, Optipharm.CO.,LTD had annual revenue of 22.34B with 13.79% growth.

• Revenue (ttm): 22.79B
• Revenue Growth: +12.51%
• P/S Ratio: 3.06
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 69.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	22.34B	2.71B	13.79%
Dec 31, 2024	19.64B	2.26B	13.03%
Dec 31, 2023	17.37B	1.36B	8.52%
Dec 31, 2022	16.01B	1.75B	12.27%
Dec 31, 2021	14.26B	1.21B	9.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error